Contraceptives in primary care Flashcards
LARC=
Long-acting reversible contraception
IUDs and Implants
Standard days method
- Must have regular cycles between 26-32 days long
- Avoid intercourse on days 8-19
- 5% failure rate for perfect use (approx. 15% typical)
Basal temperature method
- Measure temp immediately upon
waking up - Ovulation correlated with 0.6 increase
in temp - Avoid intercourse for 3 days after rise
- 10% typical failure rate
2- day method
- Avoid intercourse if had secretions on current day OR previous day
- 4% failure rate for perfect use (approx. 15% typical)
- Woman must be a secretion master
Lactational Amenorrhea
- Highly effective for women exclusively
breastfeeding during the first 6 months after
childbirth - The infant MUST be eating every 4 hrs during the day and every 6 hrs at night
- Failure rate of 0.9 -1.2% during the first 6 months; Failure rate of 7.4% at 12 months postpartum
- Another method of contraception must be used:
-as soon as menstruation resumes
-the frequency or duration of breastfeeds is
reduced
-bottle feeds are introduced
-baby reaches age 6 months
Condoms failure rates
- Failure rate perfect use= 2 %
- Failure rate typical use= 13%
- Hormone free; no side effects
- Available, inexpensive
- No prescription required
- Recommend for STI prevention (even if on a better contraceptive method)
Cervical Cap
o Small, cuplike diaphragm held in place by suction
o Must be refit each year, postpartum, and with +/- 10lbs
o Wash with mild soap and warm water
o Check it regularly by holding it up to the light
o Must tightly cover the cervix
o Each cervix is different making cervical cap fitting difficult
o Advocates recommend leaving the cap in place for 1-2 days
o However, a foul discharge often occurs after 1
day
o The cap must be left in place for 8-48 hrs
o Failure is most often due to dislodgment of the cap
Diaphragm contraceptive
o Contraceptive jelly or cream should be applied to the rim prior to insertion
o Diaphragm can be inserted up to 6 hrs prior to intercourse
o Diaphragm should be left in place for at least 6-24 hrs post coitus
o Must be refit each year, post partum, and +/- 10lbs
o Typical failure rate is 15-20%
When might a diaphragm cause vaginal wall irritation?
▪ With initial use
▪ With a device that is too tight fitting
▪ Increased risk of UTI from increased urethral
pressure
▪ May alter the composition of the vaginal flora
Combined Hormonal Contraceptives: MOA
- Exogenous estrogen & progesterone
- Suppresses GnRH from hypothalamus
- No FSH and LH release
- No follicle development
- No ovulation
- Thickening of cervical mucus, which becomes
less permeable to penetration by sperm - Thins endometrium- less suitable for implantation
- Impairment of normal tubal motility and peristalsis
CHC Contraindications
- Think estrogen → clot risk
- Contraindcated in
- <21 days postpartum
- Over 35 yo + smoking >15 cig/day (<15 cig/day is level 3)
- Previous hx of clotting disorders, angina, stroke, DVT, PE
- Migraine with aura
- Breast CA
- High 160/100+ hypertension
- Less common: Ischemic heart disease, liver cirrhosis, DM >20 yrs,
nephropathy/retinopathy/neuropathy
CHC Side Effects
o Breast tenderness, nausea, headache- <10% of patients, improve
after 1 mo.
o Weight neutral
o Mood neutral
o Libido neutral
o Breakthrough bleeding
o Blood clots/DVT
Oral Contraceptive types
- Progesterone Only (POP)/Minipill (best for breastfeeding woman)
- Combined Estrogen and Progesterone (COC)
COC Adverse Effects
- Breakthrough bleeding, which typically resolves within three months
- Mood: (likely no effect); libido: (likely no effect)
- Weight gain: no effect
- Increased risk of VTE: varies with estrogen dose and patient factors such as
age, obesity, and smoking status - COC use may slightly delay time to conception; effect is limited to the first
several months after COC discontinuation: Median time to return to menses
= 32 days - “Little to no increased risk of breast cancer” based on observational data.
Any effect appears to be temporary and limited to current or recent (within
five to seven years) COC use - Decrease effect on ovarian and endometrial CA
COC Dosing types
- Monophasic- same dose throughout all active pills
- Triphasic- dose varies throughout active pills
- Continuous- skip placebos; withdrawal bleed at 3, 6, or 12 mos.
per pt preference - Cyclic use- 21 active/7 placebo; 24 active/4 placebo
- Estrogen dose ranges- most are 20 mcg or 35 mcg per pill
COC Interactions: antibiotics
- Antibiotics: rifampin
- In spite of anecdotal reports of COC failure, other antibiotics have not been proven to affect the pharmacokinetics of ethinyl estradiol
COC Interactions: antifungals
griseofulvin
* COC failure